2020
Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer
Goldfarb S, Turan V, Bedoschi G, Taylan E, Abdo N, Cigler T, Bang H, Patil S, Dickler M, Oktay K. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer. Breast Cancer Research And Treatment 2020, 185: 165-173. PMID: 32930927, PMCID: PMC7877450, DOI: 10.1007/s10549-020-05933-7.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Mullerian HormoneBreast NeoplasmsChemotherapy, AdjuvantFemaleHumansOvarian ReserveTamoxifenConceptsAnti-Mullerian hormoneOvarian reserveAdjuvant chemotherapyBreast cancerAMH levelsChemotherapy regimensCompletion of ACSerum AMH levelsAdjuvant tamoxifenAMH recoveryChemotherapy groupPrimary diagnosisBaseline ageMethodsOne hundredAMH assessmentRegimensChemotherapyYoung womenTamoxifenSignificant recoveryCancerMixed effects modelsMonthsTreatment effectsWomen
2009
Fertility Preservation for Breast Cancer Patients
Oktem O, Oktay K. Fertility Preservation for Breast Cancer Patients. Seminars In Reproductive Medicine 2009, 27: 486-492. PMID: 19806518, DOI: 10.1055/s-0029-1241059.Peer-Reviewed Original ResearchConceptsBreast cancer patientsOvarian stimulation protocolsCancer patientsBreast cancerFertility preservationCancer survivorsStimulation protocolConventional ovarian stimulation protocolsRise of estrogenOvarian tissue freezingBreast cancer survivorsPreservation of fertilityEndogenous estrogen levelsFertility preservation strategiesAromatase inhibitor letrozolePremature ovarian failureNew cancer casesAdjuvant chemotherapyOvarian stimulationFertilization cyclesEstrogen levelsOvarian failureOocyte freezingReproductive ageCommon neoplasm